Teleflex to acquire Biotronik's vascular intervention business for $791M, split into 2 separate entities

Retrieved on: 2025-02-27 22:29:09

Tags for this article:

Click the tags to see associated articles and topics

Teleflex to acquire Biotronik's vascular intervention business for $791M, split into 2 separate entities. View article details on hiswai:

Excerpt

This strategic shift empowers us to amplify our investments in emerging technologies across cardiac rhythm management, patient monitoring, heart ...

Article found on: cardiovascularbusiness.com